Crowdonomics
BioXgen Holdings, Inc.

Reg CF · Common Stock · Jan 2026

OpenReached targetReg CFCommon Equity
via DealMaker · last checked Oct 9, 2026View campaign
Raised
$83.9K / $5M max
2% of ceiling · target hit day 237
Investors
52
$1.6K avg
Momentum
$312/day
best $6K · 90 days left

Raised over time

Cumulative raisedInvestors
$84K$42K$0
52260
Jan 14, 2026 · openedOct 9, 2026 · latest
Target ($25K) hit — Sep 8, 2026, day 237Deadline Jan 8, 2027 — 91 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via DealMaker, last checked Oct 9, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
FY2023
$0
FY2024
RevenueNet income
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$160,000
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

2 amendments
  1. Apr 30, 2026
    • Deadline May 15, 2026 → Jan 8, 2027
    • Maximum $5M → $1.2M

    “This material amendment is filed to include FYE 2025 reviewed financials and update the Offering Deadline.”

    Form C/A on EDGAR ↗
  2. Jan 14, 2026
    No change to filed terms

    “This immaterial amendment is filed to add perks to the Offering.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Est. pre-money$85.8M
Price / share$1.43
Shares offered16,892

Estimated, not stated: $1.43 × 60,000,000 securities outstanding as of Jan 14, 2026 (Form C filed Jan 14, 2026, p. 14).

Offering details

Target$25,000
Max$5,000,000
Min investment—
OpenedJan 14, 2026
DeadlineJan 8, 2027
Days active269
Days to deadline90

Links & provenance

Source: SEC EDGAR
0001872856-26-000012
Last synced Oct 5, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.